Literature DB >> 28502261

Profiles of Executive Function Across Children with Distinct Brain Disorders: Traumatic Brain Injury, Stroke, and Brain Tumor.

Gabriel C Araujo1, Tanya N Antonini2, Vicki Anderson3, Kathryn A Vannatta4, Christina G Salley5, Erin D Bigler6, H Gerry Taylor7, Cynthia Gerhardt4, Kenneth Rubin8, Maureen Dennis9, Warren Lo10, Mark T Mackay11, Anne Gordon12, Christine Hajek Koterba13, Alison Gomes14, Mardee Greenham15, Keith Owen Yeates16.   

Abstract

OBJECTIVES: This study examined whether children with distinct brain disorders show different profiles of strengths and weaknesses in executive functions, and differ from children without brain disorder.
METHODS: Participants were children with traumatic brain injury (N=82; 8-13 years of age), arterial ischemic stroke (N=36; 6-16 years of age), and brain tumor (N=74; 9-18 years of age), each with a corresponding matched comparison group consisting of children with orthopedic injury (N=61), asthma (N=15), and classmates without medical illness (N=68), respectively. Shifting, inhibition, and working memory were assessed, respectively, using three Test of Everyday Attention: Children's Version (TEA-Ch) subtests: Creature Counting, Walk-Don't-Walk, and Code Transmission. Comparison groups did not differ in TEA-Ch performance and were merged into a single control group. Profile analysis was used to examine group differences in TEA-Ch subtest scaled scores after controlling for maternal education and age.
RESULTS: As a whole, children with brain disorder performed more poorly than controls on measures of executive function. Relative to controls, the three brain injury groups showed significantly different profiles of executive functions. Importantly, post hoc tests revealed that performance on TEA-Ch subtests differed among the brain disorder groups.
CONCLUSIONS: Results suggest that different childhood brain disorders result in distinct patterns of executive function deficits that differ from children without brain disorder. Implications for clinical practice and future research are discussed. (JINS, 2017, 23, 529-538).

Entities:  

Keywords:  Executive functions; Inhibition; Pediatric brain disorders; Shifting; TEA-Ch; Working memory

Mesh:

Year:  2017        PMID: 28502261     DOI: 10.1017/S1355617717000364

Source DB:  PubMed          Journal:  J Int Neuropsychol Soc        ISSN: 1355-6177            Impact factor:   2.892


  5 in total

1.  Long-term Sequelae of Pediatric Neurocritical Care: The Parent Perspective.

Authors:  Cydni N Williams; Carl Eriksson; Juan Piantino; Trevor Hall; Danielle Moyer; Aileen Kirby; Cindy McEvoy
Journal:  J Pediatr Intensive Care       Date:  2018-03-09

2.  Effects of supratentorial and infratentorial tumor location on cognitive functioning of children with brain tumor.

Authors:  Claudia Corti; Cosimo Urgesi; Maura Massimino; Lorenza Gandola; Alessandra Bardoni; Geraldina Poggi
Journal:  Childs Nerv Syst       Date:  2019-12-12       Impact factor: 1.475

3.  If You Build It, They Will Come: Initial Experience with a Multi-Disciplinary Pediatric Neurocritical Care Follow-Up Clinic.

Authors:  Cydni N Williams; Aileen Kirby; Juan Piantino
Journal:  Children (Basel)       Date:  2017-09-19

4.  Assessment of Executive Function in Everyday Life-Psychometric Properties of the Norwegian Adaptation of the Children's Cooking Task.

Authors:  Torun G Finnanger; Stein Andersson; Mathilde Chevignard; Gøril O Johansen; Anne E Brandt; Ruth E Hypher; Kari Risnes; Torstein B Rø; Jan Stubberud
Journal:  Front Hum Neurosci       Date:  2022-02-03       Impact factor: 3.169

5.  Prescribing Patterns of Amantadine During Pediatric Inpatient Rehabilitation After Traumatic Brain Injury: A Multicentered Retrospective Review From the Pediatric Brain Injury Consortium.

Authors:  Matthew J McLaughlin; Eric Caliendo; Ryan Lowder; William D Watson; Brad Kurowski; Katherine T Baum; Laura S Blackwell; Christine H Koterba; Kristen R Hoskinson; Sarah J Tlustos; Kanecia O Zimmerman; Sudhin A Shah; Stacy J Suskauer
Journal:  J Head Trauma Rehabil       Date:  2021-07-26       Impact factor: 3.117

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.